Navigation Links
TELITHROMYCIN - the proven effective new drug for cap

Community acquired pneumonia other wise known as CAP has been a therapeutic challenge to most of the practising physicians. This is mainly due to the growing resistance of the bacteria causing them to the available antibiotics.

Telithromycin (Ketek), a new ketolide antibiotic, is highly effective in treating patients with pneumococcal bacteraemia associated with community-acquired pneumonia (CAP). This is a breakthrough in the field of anti microbials as pneumococcal resistance is on the rage. Dr. Thomas M. File, Jr., of Northeastern Ohio University of Medicine, Rootstown, commented that, "Currently clinicians who perceive their patients to be at risk for infection with resistant pathogens are relying on one or two classes of antimicrobials. This results in increased pressure on those classes ", and this infact is responsible for the resistance strains of this group of bacteria.

The efficacy of the drug was assessed by five clinical trials and clinical and biological outcomes was noted. Blood samples were taken before and after the therapy for both aerobic and anaerobic culture. It was found that, the overall clinical cure rate with telithromycin was 89.5% after 7 to 11 days of therapy.

Telithromycin has recently been approved by the US Food and Drug Administration for the treatment of CAP, acute bacterial exacerbation of chronic bronchitis (ABECB), and acute bacterial sinusitis (ABS) and is marketed by Aventis Pharma.
'"/>




Page: 1

Related medicine news :

1. Partial-Breast Irradiation an Unproven Therapy
2. New drug proven to tackle Type 2 Diabetes
3. Morning after pill effective up to five days after having unprotected sex
4. Distraction therapy found very effective in postoperative patients
5. Digital mammography proves effective
6. Treatment for pre-menstrual syndrome is ineffective
7. Cost-effective antibiotics for sinusitis treatment
8. An effective way to treat angina
9. Fluoride proves effective against fractures
10. Meningitis C vaccine a cost-effective success
11. An effective drug for lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... ... , ... Valentine’s Day is nearly upon us, and most singles could probably ... flawless hair, and a sparkling personality are all well and good, but if somebody ... home with Rover. (Actually, man’s best friend might not even want to be near ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly ... vein visualization technology should be used to ensure patient safety when placing an ... INS Standards mandate the use of vein visualization technology in patients with difficult ...
(Date:2/12/2016)... ... 12, 2016 , ... According to an article published February 4th ... significant portion of hernia repairs throughout the United States. Commenting on this article, Beverly ... that this trend has not only been expected, but it seems to be a ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a ... closed for the ISE Southeast Awards 2016. Finalists and winners of the ISE® ... Southeast Executive Forum and Awards Gala on March 15, 2016 at the Westin ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... February 12, 2016 ... vermerkt)   http://www.sedar.com ) und ... abrufbar.    --> http://www.sedar.com ... http://www.telestatherapeutics.com abrufbar.    --> ... heute seinen Konzernabschluss des zweiten Quartals ...
(Date:2/12/2016)...  Memorial Hermann Health System has teamed up with ... bring a one-of-a-kind experience to pediatric patients at ... as 360-degree video and Google Cardboard, Howard was able ... giving the patients and their families an unexpected, and ... on video . Memorial Hermann IRONMAN ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
Breaking Medicine Technology: